The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial
出版年份 2015 全文链接
标题
The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial
作者
关键词
-
出版物
JOURNAL OF PSYCHOPHARMACOLOGY
Volume 30, Issue 2, Pages 140-151
出版商
SAGE Publications
发表日期
2015-11-18
DOI
10.1177/0269881115615104
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The phytocannabinoid, Δ9-tetrahydrocannabivarin, can act through 5-HT1Areceptors to produce antipsychotic effects
- (2015) Maria Grazia Cascio et al. BRITISH JOURNAL OF PHARMACOLOGY
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9-tetrahydrocannabivarin (THCV), to produce CB1receptor inverse agonism symptoms of nausea in rats
- (2013) Erin M Rock et al. BRITISH JOURNAL OF PHARMACOLOGY
- A review of the cultivation and processing of cannabis (Cannabis sativaL.) for production of prescription medicines in the UK
- (2013) David J. Potter Drug Testing and Analysis
- Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report
- (2013) Mateus M. Bergamaschi et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
- (2013) E T Wargent et al. Nutrition & Diabetes
- Cannabis in the Arm: What Can we Learn from Intravenous Cannabinoid Studies?
- (2012) Amir Englund et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Synthetic delta-9-tetrahydrocannabinol elicits schizophrenia-like negative symptoms which are distinct from sedation
- (2011) P. D. Morrison et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing
- (2011) Jamie Horder et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Communication breakdown: delta-9 tetrahydrocannabinol effects on pre-speech neural coherence
- (2011) J M Stone et al. MOLECULAR PSYCHIATRY
- The safety of studies with intravenous Δ9-tetrahydrocannabinol in humans, with case histories
- (2011) Michelle Carbuto et al. PSYCHOPHARMACOLOGY
- Cannabis with high cannabidiol content is associated with fewer psychotic experiences
- (2011) Christian D. Schubart et al. SCHIZOPHRENIA RESEARCH
- Rimonabant for neurocognition in schizophrenia: A 16-week double blind randomized placebo controlled trial
- (2011) Douglas L. Boggs et al. SCHIZOPHRENIA RESEARCH
- Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
- (2010) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Potency Trends of Δ9-THC and Other Cannabinoids in Confiscated Cannabis Preparations from 1993 to 2008*
- (2010) Zlatko Mehmedic et al. JOURNAL OF FORENSIC SCIENCES
- Disruption of Frontal Theta Coherence by Δ9-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms
- (2010) Paul D Morrison et al. NEUROPSYCHOPHARMACOLOGY
- The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
- (2009) P. D. Morrison et al. PSYCHOLOGICAL MEDICINE
- Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers
- (2009) Jamie Horder et al. PSYCHOPHARMACOLOGY
- Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids
- (2008) Lumír Ondřej Hanuš MEDICINAL RESEARCH REVIEWS
- Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis
- (2008) Deepak Cyril D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- The psychoactive plant cannabinoid, Δ9-tetrahydrocannabinol, is antagonized by Δ8- and Δ9-tetrahydrocannabivarin in mice in vivo
- (2007) R G Pertwee et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now